Cited by

• Tuberculosis and HIV co-infection.

  Pawlowski A, Jansson M, Sköld M, Rottenberg ME, Källenius G. Pawlowski A, et al. PLoS Pathog. 2012 Feb;8(2):e1002464. doi: 10.1371/journal.ppat.1002464. Epub 2012 Feb 16. PLoS Pathog. 2012. PMID: 22363214 Free PMC article. Review.
• Adaptive immunity in different CT patterns of active tuberculosis and possible variability according to patients' geographic provenience.

  Scioscia G, Lacedonia D, Giuffreda E, Caccavo I, Quarato CMI, Soccio P, Tondo P, Sassani EV, Pescatore D, Foschino Barbaro MP. Scioscia G, et al. Front Med (Lausanne). 2022 Sep 7;9:890609. doi: 10.3389/fmed.2022.890609. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36160177 Free PMC article.
• Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.

  Axelsson-Robertson R, Weichold F, Sizemore D, Wulf M, Skeiky YA, Sadoff J, Maeurer MJ. Axelsson-Robertson R, et al. Immunology. 2010 Apr;129(4):496-505. doi: 10.1111/j.1365-2567.2009.03201.x. Epub 2009 Nov 25. Immunology. 2010. PMID: 20002212 Free PMC article.
• Analysis of the Healthy Subject Response to Prolonged Contact with Tuberculosis Patients.

  Litvinov IS, Dolgikh DA. Litvinov IS, et al. Dokl Biol Sci. 2019 Sep;488(1):153-155. doi: 10.1134/S001249661905003X. Epub 2019 Nov 15. Dokl Biol Sci. 2019. PMID: 31732902
• Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology.

  Cicchese JM, Evans S, Hult C, Joslyn LR, Wessler T, Millar JA, Marino S, Cilfone NA, Mattila JT, Linderman JJ, Kirschner DE. Cicchese JM, et al. Immunol Rev. 2018 Sep;285(1):147-167. doi: 10.1111/imr.12671. Immunol Rev. 2018. PMID: 30129209 Free PMC article. Review.